Valeant Names SVP and Corporate Controller

From DCAT Value Chain Insights (VCI)

By People On The Move posted 06-01-2016 17:03


Sam Eldessouky has been named senior vice president and corporate controller of Valeant Pharmaceuticals International, effective May 31, 2016. Mr. Eldessouky, who has over 20 years of experience in accounting and finance, joins Valeant from Tyco International Plc, where he served since 2004, most recently as senior vice president, controller and chief accounting officer.

In his role, Mr. Eldessouky will be responsible for directing global accounting and financial reporting activities to ensure accurate and timely compliance with all internal and external requirements, and he will drive efficiencies and standardization throughout the global accounting function to enhance the monthly close, consolidations, controls and reporting processes. Mr. Eldessouky will report directly to Valeant's Chief Financial Officer, Robert Rosiello.

As senior vice president, controller, and chief accounting ffficer for Tyco since 2011, Mr. Eldessouky was responsible for overseeing the finance shared services functions, external reporting, technical accounting, operational controllership, valuation and M&A accounting, treasury accounting, global consolidation, internal controls, accounting policy and training programs. Prior to this role, Mr. Eldessouky served in a variety of positions at Tyco, including vice president and assistant controller. Before joining Tyco, Mr. Eldessouky spent 10 years at PricewaterhouseCoopers (PwC), where he held several roles of increasing responsibility and served in PwC's National Office providing technical accounting guidance on complex accounting matters.

Source: Valeant Pharmaceuticals International


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription